5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move

Pfizer (PFE -0.68%) has seen its better days. Shares of the big drugmaker have plunged more than 50% from the highs set in late 2021. The pharma stock is down more than 30% over the last 12 months. Sales and profits have fallen sharply.Should investors avoid the beaten-down stock like the plague? I don't think so. Here are five reasons why buying this 6%-yielding dividend stock could be a brilliant move.1. COVID-19 troughMost of Pfizer's recent woes can be blamed on declining demand for its COVID-19 product ...